… as it pertains to genetic risk factors, exogenous hormonal therapies, pregnancy, surgery,
medical hospitalization, cancer, and what is known thus far about VTE in COVID-19 infection. …

… , the thromboembolic complications of COVID-19 and their … of data on thromboembolic
complications of COVID-19, which will be … Given the bleeding risks associated with anticoagulants, …

… events along with lack of pre-existing thromboembolic risk factors in these patients makes the
… the benefits of COVID-19 vaccination definitely outweigh the minor risks associated with it. …

… create a risk prediction model for VTE in hospitalized patients with COVID-19 using clinical
… of the thrombotic risk in the immediate period after patients with COVID-19 are discharged …

… of the thromboembolic risks associated with COVID-19 (Table 6). These guidance
statements have been developed in the absence of randomized controlled trials in patients with …

… Many patients with COVID-19 are at increased risk of venous thromboembolism (VTE).
Therefore, we recommend pharmacologic prophylaxis for patients with COVID-19 when …

… of VTE in critically ill patients with COVID‐19, which is consistent with … risk group for
adverse outcomes and to raise clinicians’ awareness of VTE risk amongst critically ill COVID‐19 …

… First, we will describe the risk for VTE in patients hospitalized with COVID-19 and explore …
risk estimates. Second, we will compare the risk of VTE in hospitalized patients with COVID-19 …

… had little impact on risk of VTE or mortality in previous studies of COVID-19 and was associated
… for aggressive thromboprophylaxis in COVID-19 patients is uncertain and risk-benefit of …

… or darunavir/ritonavir which increase the bleeding risk by inhibiting Cytochrome P450 3A4
(… prophylaxis in COVID-19 infected patients based on the patient's condition and risk factors. …